tiprankstipranks
Advertisement
Advertisement

TSE:TELO Stock Latest News

Company AnnouncementsTelo Genomics Advances Blood-Based MRD Testing in Myeloma with New Study and CAP Accreditation
21d ago
PremiumCompany Announcements
Telo Genomics Installs New CEO and Chairman as It Prepares for Pivotal Oncology Milestones
1M ago
PremiumCompany Announcements
Telo Genomics Raises $1.39 Million in Final Convertible Debenture Tranche
2M ago
PremiumCompany Announcements
Telo Genomics Upsizes Convertible Debenture Financing to $1.6 Million
2M ago
PremiumCompany Announcements
Telo Genomics Raises $840,000 in First Tranche of Convertible Debenture Financing
2M ago
Telo Genomics Strengthens Finance Team With Appointment of Veteran CFO John Price
PremiumCompany AnnouncementsTelo Genomics Strengthens Finance Team With Appointment of Veteran CFO John Price
3M ago
Telo Genomics Seeks Up to $1.2 Million via Convertible Debenture Financing
Premium
Company Announcements
Telo Genomics Seeks Up to $1.2 Million via Convertible Debenture Financing
4M ago
Telo Genomics Expands Multiple Myeloma MRD Validation with University of Athens Study
Premium
Company Announcements
Telo Genomics Expands Multiple Myeloma MRD Validation with University of Athens Study
5M ago
Telo Genomics Unveils Innovative Myeloma Testing at ASH Meeting
PremiumCompany Announcements
Telo Genomics Unveils Innovative Myeloma Testing at ASH Meeting
5M ago
Telo Genomics Unveils Advanced MRD Technology at Myeloma Summit
PremiumCompany Announcements
Telo Genomics Unveils Advanced MRD Technology at Myeloma Summit
6M ago
Telo Genomics’ MRD Technology Gains Recognition at ASH 2025
PremiumCompany Announcements
Telo Genomics’ MRD Technology Gains Recognition at ASH 2025
7M ago
Telo Genomics Expands with New Toronto Facility and Board Update
PremiumCompany Announcements
Telo Genomics Expands with New Toronto Facility and Board Update
7M ago
Telo Genomics Unveils Innovative MRD Methodology at Myeloma Society Meeting
PremiumCompany AnnouncementsTelo Genomics Unveils Innovative MRD Methodology at Myeloma Society Meeting
8M ago
Telo Genomics Engages Hayden IR for Investor Relations Enhancement
Premium
Company Announcements
Telo Genomics Engages Hayden IR for Investor Relations Enhancement
8M ago
Telo Genomics to Showcase New Strategy at OTCQB Virtual Investor Conference
Premium
Company Announcements
Telo Genomics to Showcase New Strategy at OTCQB Virtual Investor Conference
9M ago
Telo Genomics’ MRD Abstract Accepted for Presentation at International Myeloma Society Meeting
PremiumCompany Announcements
Telo Genomics’ MRD Abstract Accepted for Presentation at International Myeloma Society Meeting
9M ago
Telo Genomics to Contest Former President’s Lawsuit
PremiumCompany Announcements
Telo Genomics to Contest Former President’s Lawsuit
10M ago
Telo Genomics Launches Clinical Trial for Enhanced Multiple Myeloma Assessment
PremiumCompany Announcements
Telo Genomics Launches Clinical Trial for Enhanced Multiple Myeloma Assessment
11M ago
Telo Genomics Advances IP Strategy with New Tier Status from IPON
PremiumCompany Announcements
Telo Genomics Advances IP Strategy with New Tier Status from IPON
11M ago
Telo Genomics’ SMM Risk Prediction Abstract Accepted for EHA 2025 Congress
PremiumCompany AnnouncementsTelo Genomics’ SMM Risk Prediction Abstract Accepted for EHA 2025 Congress
12M ago
Telo Genomics’ MRD Data in Multiple Myeloma Gains ASCO Recognition
Premium
Company Announcements
Telo Genomics’ MRD Data in Multiple Myeloma Gains ASCO Recognition
1y ago
Telo Genomics Strengthens Leadership with New Board Appointment
Premium
Company Announcements
Telo Genomics Strengthens Leadership with New Board Appointment
1y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >